$3.89
0.174.57%
At close: -
$3.94
0.051.29%
After Hours: Dec 20, 6:56 PM EDT
Alto Neuroscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Alto Neuroscience using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.62 | $-0.64 | 3.12 % |
Jun 2024 | 2024-08-13 | $-0.60 | $-0.63 | 4.76 % |
Mar 2024 | 2024-05-14 | $-0.76 | $-0.46 | -65.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Alto Neuroscience (ANRO) is scheduled to report earnings on February 2, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.62, which beat the estimate of $-0.64.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.